Aaron Strickland is the Co-founderand VP of R&D of iFyber, the parent company to NovaSterilis where he servesas their Chief Science Officer.  Aaronhas over 20 years of research experience across a diverse array of fields,including synthetic chemistry, analytical chemistry, microbiology and molecularbiology, and nanotechnology. Aaron leads multidisciplinary teams as theprincipal investigator and study director on both corporate-funded projects andfederal grants and contracts for numerous federal agencies.  Aaron is currently leading an NIH-fundedeffort to explore scCO2-basedsterilization of drug substances and drug products.

Aaron received his Ph.D. inchemistry from the University of Wyoming and performed postdoctoral work inmicrobiology and biotechnology at Cornell University as a National ScienceFoundation Fellow.